Novitas Capital

Agile Therapeutics, Inc. is a women's healthcare company based in Princeton, New Jersey, dedicated to the research, development, and commercialization of prescription contraceptive products. The company's lead product is Twirla, a once-weekly transdermal contraceptive patch that combines levonorgestrel and ethinyl estradiol, designed to provide a non-daily option for contraception. Agile Therapeutics is also advancing a pipeline of additional products and extensions related to Twirla, including regimens aimed at offering women extended cycles, shorter and lighter periods, and a progestin-only patch for those who cannot or prefer not to use estrogen. Utilizing proprietary Skinfusion technology, the company aims to deliver effective contraceptive solutions that address the unmet health needs of women today. Founded in 1997, Agile Therapeutics continues to focus on innovating women's healthcare options.

Nistica, Inc. is a developer and manufacturer of optical networking modules focused on delivering high-bandwidth applications. Established in January 2005 and headquartered in Bridgewater, New Jersey, the company specializes in agile optical modules designed for optical system original equipment manufacturers globally. Nistica's product offerings include reconfigurable optical add/drop multiplexer (ROADM) subsystems, low port-count wavelength selective switch modules, and high port-count series products. These solutions facilitate flexible channel plans and dynamic power equalization, enabling users to customize channel spacing. Additionally, Nistica provides advanced products such as FLEXBOX, a disaggregated ROADM node aimed at software-defined networks. The company's innovative approach simplifies and automates optical network delivery, enhancing the capabilities of both edge and metro core networks. In June 2012, Nistica was acquired by Molex Optical Solutions Group, further extending its reach and impact in the optical networking industry.

Agile Therapeutics, Inc. is a women's healthcare company based in Princeton, New Jersey, dedicated to the research, development, and commercialization of prescription contraceptive products. The company's lead product is Twirla, a once-weekly transdermal contraceptive patch that combines levonorgestrel and ethinyl estradiol, designed to provide a non-daily option for contraception. Agile Therapeutics is also advancing a pipeline of additional products and extensions related to Twirla, including regimens aimed at offering women extended cycles, shorter and lighter periods, and a progestin-only patch for those who cannot or prefer not to use estrogen. Utilizing proprietary Skinfusion technology, the company aims to deliver effective contraceptive solutions that address the unmet health needs of women today. Founded in 1997, Agile Therapeutics continues to focus on innovating women's healthcare options.

Nistica, Inc. is a developer and manufacturer of optical networking modules focused on delivering high-bandwidth applications. Established in January 2005 and headquartered in Bridgewater, New Jersey, the company specializes in agile optical modules designed for optical system original equipment manufacturers globally. Nistica's product offerings include reconfigurable optical add/drop multiplexer (ROADM) subsystems, low port-count wavelength selective switch modules, and high port-count series products. These solutions facilitate flexible channel plans and dynamic power equalization, enabling users to customize channel spacing. Additionally, Nistica provides advanced products such as FLEXBOX, a disaggregated ROADM node aimed at software-defined networks. The company's innovative approach simplifies and automates optical network delivery, enhancing the capabilities of both edge and metro core networks. In June 2012, Nistica was acquired by Molex Optical Solutions Group, further extending its reach and impact in the optical networking industry.

Nistica, Inc. is a developer and manufacturer of optical networking modules focused on delivering high-bandwidth applications. Established in January 2005 and headquartered in Bridgewater, New Jersey, the company specializes in agile optical modules designed for optical system original equipment manufacturers globally. Nistica's product offerings include reconfigurable optical add/drop multiplexer (ROADM) subsystems, low port-count wavelength selective switch modules, and high port-count series products. These solutions facilitate flexible channel plans and dynamic power equalization, enabling users to customize channel spacing. Additionally, Nistica provides advanced products such as FLEXBOX, a disaggregated ROADM node aimed at software-defined networks. The company's innovative approach simplifies and automates optical network delivery, enhancing the capabilities of both edge and metro core networks. In June 2012, Nistica was acquired by Molex Optical Solutions Group, further extending its reach and impact in the optical networking industry.

MedCases focuses on the development of medical e-learning solutions for the pharmaceutical and biotechnology industry. MedCases offers ADHD Point of Care CME Program that focuses on educating physicians on the diagnosis and treatment of attention-deficit hyperactivity disorder. MedCases was acquired by Indegene Lifesystems in November 2006. MedCases was founded in 1971 and is based in Princeton, New Jersey.